food and drug administration

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

The FDA started the process of issuing guidance on CBD products.  Democrats said no to legalized marijuana in their party platform.  There’s a way to test products for cannabis levels.  Missouri is having problems with its

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Ballot initiatives make news in several states.  The Food and Drug Administration released guidance on marijuana research.  Two state officials publicly support legal marijuana.  We’ve got yet another report on the National Defense Authorization Act.  And

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Our top story this week is a bill that would allow cannabis companies to receive federal stimulus money, and the support it has attracted.  Ballot issues continue in Florida and Montana.  The FDA is cracking down

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Let’s start off with the big news: the SAFE Act passed in the House.  For news coverage, see here, here and here.  For our take on this legislation (spoiler alert: we’re not so sanguine

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Sadly, the big news this week is vaping.  Hundreds are sick and several have died, apparently as a result of using e-cigarettes and other vaping products.  As a result, the cannabis industry expects fallout from this

CBD is “thriving” in the current regulatory environment, but is it doing so illegally?

As former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb opined last  week, “the CBD craze is getting out of hand. The FDA needs to act.”  Since the passage of the Farm Bill in December of 2018, there has been a marked uptick in interest in the cannabidiol (CBD) space from businesses and users alike.  Congress explicitly preserved the FDA’s authority to regulate CBD-containing products to ensure that they are safe and that their claims are valid.  Current federal law expressly allows for the distribution of hemp-derived CBD products that contain 0.3% tetrahydrocannabidiol (THC) or less to be sold, with certain caveats.  The FDA has provided clarity that hulled hemp seed, hemp protein powder, and hemp seed oil can be legally used in foods.  Other CBD products, however, are still subject to various state law regulations as well as the U.S. Food, Drug, and Cosmetic Act (FD&C Act), which requires FDA pre-market approval for drug products.  Currently, the FDA treats CBD products aimed at human or animal consumption as drugs and therefore they cannot be distributed without prior approval or a rulemaking exception (more on this below).  The following is a brief update on recent developments within the federal regulatory regime of CBD products. 
Continue Reading CBD is Everywhere – But Where Does the FDA Stand?

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Let’s start with Congress, which had a very busy week.  On Tuesday, the Senate Banking Committee had a hearing on cannabanking.  Full video, as well as member statements and witness testimony are available at the

In Dallas, a yoga studio offers CBD-infused kombucha.

In Philadelphia, a decorated chef serves an elegant CBD-infused four-course meal to a nattily dressed group of fifty.

In Kentucky, the Peaches & CBD Cream burger competes in Lexington Burger Week.

A vendor at an arts festival in Colorado offers CBD Hot Dogs from his hot dog cart.

In Minnesota, a brewer offers a pint of craft beer that contains 13mg of CBD.
Continue Reading CBD: Uncertainty for Restaurants and Retailers